If you follow the developments in the medical field and the biotechnology industry, you must have come across a cancer treatment called Anti-body Drug Conjugate (ADC). Cancer is a disease that claims lives in a very short time. The disease is known to waste the health of the patient and leave them at the mercy of drugs and chemotherapy sessions. However, thanks to research there are scientists who have discovered a drug technology which can help these patients.
The ADC technology works in a way that the cells which have cancer are killed. The good news is that the cells which have no cancer are not affected by the toxicity of the chemotherapy sessions which patient undergoes. The agents are sent to kill cells with cancer only. The innovative technology will ensure that patients suffering cancer do not die or take long to cure after their chemotherapy sessions are over.
The success of Seattle Genetics can be attributed to the leadership and management of the company. The founder of the company, who is also the CEO, Dr. Clay Siegall co-founded the company in 1998. The original plan was to offer the biotechnology industry with innovative medical solutions for diseases such as cancer. The team at Seattle Genetics has dedicated their time and resources to finding innovative treatment alternatives such as the recently launched ADC treatment options.
Most people know Mr. Siegall as an entrepreneur but they are not aware of the fact that by profession, he is a scientist. He is trained and he specialises in the area of therapies. He is also interested in the area of drug development. As a business mogul and reputed entrepreneur, Mr. Siegall has been the recipient of various awards and accolades. He was, for example, given an award by Ernst & Young in 2012, for being the Entrepreneur of the Year.
For the biotechnology and the biomedical industry, the ADC treatment alternative is welcome news. The technology will help more patients get treatment and recuperate faster after their therapies are done. The company is dedicate towards offering more biomedical solutions in an innovative manner.
Learn more about Clay Siegall